[go: up one dir, main page]

AU3117799A - Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders - Google Patents

Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders

Info

Publication number
AU3117799A
AU3117799A AU31177/99A AU3117799A AU3117799A AU 3117799 A AU3117799 A AU 3117799A AU 31177/99 A AU31177/99 A AU 31177/99A AU 3117799 A AU3117799 A AU 3117799A AU 3117799 A AU3117799 A AU 3117799A
Authority
AU
Australia
Prior art keywords
diagnosing
identifying
neurodegenerative disorders
synuclein positive
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31177/99A
Inventor
Takeshi Iwatsubo
Virginia M-Y. Lee
John Q. Trojanowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU3117799A publication Critical patent/AU3117799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
AU31177/99A 1998-03-30 1999-03-29 Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders Abandoned AU3117799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8001598P 1998-03-30 1998-03-30
US60080015 1998-03-30
US9538398P 1998-08-05 1998-08-05
US60095383 1998-08-05
PCT/US1999/006710 WO1999050300A1 (en) 1998-03-30 1999-03-29 Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders

Publications (1)

Publication Number Publication Date
AU3117799A true AU3117799A (en) 1999-10-18

Family

ID=26762902

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31177/99A Abandoned AU3117799A (en) 1998-03-30 1999-03-29 Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders

Country Status (2)

Country Link
AU (1) AU3117799A (en)
WO (1) WO1999050300A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203446D0 (en) * 2002-02-14 2002-04-03 Univ Lancaster Detection and/or monitoring of synuclein-related diseases
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
WO2008103472A2 (en) 2007-02-23 2008-08-28 Elan Pharmaceuticals, Inc. Prevention and treatment of synucleinopathic and amyloidogenic disease
US9034337B2 (en) 2003-10-31 2015-05-19 Prothena Biosciences Limited Treatment and delay of outset of synucleinopathic and amyloidogenic disease
US20080014194A1 (en) 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
US8697082B2 (en) 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US7605249B2 (en) 2002-11-26 2009-10-20 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7618948B2 (en) 2002-11-26 2009-11-17 Medtronic, Inc. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
US7829694B2 (en) 2002-11-26 2010-11-09 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of siRNA
US7994149B2 (en) 2003-02-03 2011-08-09 Medtronic, Inc. Method for treatment of Huntington's disease through intracranial delivery of sirna
US7358331B2 (en) * 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
PL2361928T3 (en) * 2003-05-19 2017-09-29 Prothena Biosciences Limited Truncated fragments of alpha-synuclein in Lewy body disease
US7674599B2 (en) 2003-11-08 2010-03-09 Elan Pharmaceuticals, Inc. Methods of using antibodies to detect alpha-synuclein in fluid samples
ES2310057B1 (en) * 2004-07-19 2009-11-17 Oryzon Genomics, S.A. METHOD OF MOLECULAR ANALYSIS AND TREATMENT IN DEMENTIA OF LEWY BODIES.
US9133517B2 (en) 2005-06-28 2015-09-15 Medtronics, Inc. Methods and sequences to preferentially suppress expression of mutated huntingtin
US9273356B2 (en) 2006-05-24 2016-03-01 Medtronic, Inc. Methods and kits for linking polymorphic sequences to expanded repeat mutations
US9375440B2 (en) 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
HRP20140049T1 (en) 2007-01-05 2014-02-28 University Of Zürich Anti-beta-amyloid antibody and uses thereof
US8147833B2 (en) 2007-02-23 2012-04-03 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
GB0716885D0 (en) 2007-08-30 2007-10-10 United Arab Emirates Universit Diagnostic agent
WO2010069603A1 (en) 2008-12-19 2010-06-24 Neurimmune Therapeutics Ag Human anti-alpha-synuclein autoantibodies
CN103796679B (en) 2011-06-23 2016-10-19 比奥根国际神经科学公司 Anti-α synapse nucleoprotein binding molecule
KR102036938B1 (en) * 2011-11-02 2019-10-25 바이오겐 인터내셔널 뉴로사이언스 게엠베하 USE OF AN ANTI-α-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF α-SYNUCLEIN IN THE BRAIN
KR20140018691A (en) * 2012-08-03 2014-02-13 가천대학교 산학협력단 Diagnostic method for ssynucleinopathy and diagnostic kit therefor
EP3961216B1 (en) 2014-11-14 2024-02-14 United Arab Emirates University Dihydromyricetin for use as imaging agent
MA41115A (en) 2014-12-02 2017-10-10 Biogen Int Neuroscience Gmbh ALZHEIMER'S DISEASE TREATMENT PROCESS
EP3091087A1 (en) 2015-05-08 2016-11-09 Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Method for in vitro diagnosis of synucleinopathies using alpha-synuclein gene transcripts
CA3073066A1 (en) 2017-08-22 2019-02-28 Biogen Ma Inc. Pharmaceutical compositions containing anti-beta amyloid antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998059050A1 (en) * 1997-06-25 1998-12-30 The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services Cloning of a gene mutation for parkinson's disease

Also Published As

Publication number Publication date
WO1999050300A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
AU3117799A (en) Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders
IL176601A0 (en) Method for diagnosing and improving vision
AU1717600A (en) Methods for identification and verification
AU2653199A (en) Pseudospontaneous neural stimulation system and method
AU1306199A (en) Method and apparatus for treating oropharyngeal disorders with e lectrical stimulation
AU1994495A (en) Method of analyzing sleep disorders
AU2001243273A1 (en) System and method for diagnosing pathologic heart conditions
GB9822626D0 (en) Verification method
AUPO616697A0 (en) Method for diagnosing psychiatric disorders
AU4366999A (en) Vehicle treatment installation and operating method
AU6589798A (en) Ileus treatment method
AU2676397A (en) Methods for treating middle and inner ear disorders
AU2889299A (en) Formation testing apparatus and method
AU5787999A (en) Method for treating neurodegenerative disorders
AU5551299A (en) Method of identifying proteins
AU5362598A (en) Method for improving wastewater treatment
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
GB2304411B (en) Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
AU5733099A (en) Method for treating ocular neovascular diseases
AU3121697A (en) Cryptosporidium detection method
AU6105199A (en) Diagnostic method
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
AU2937199A (en) Method for diagnosing epilepsy and related disorders, and kit therefor
GB9821001D0 (en) Process monitoring and control methods
AU4354097A (en) Wire pair identification method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase